» Articles » PMID: 29626746

Experiences with Skin and Soft Tissue Infections Among People Who Inject Drugs in Philadelphia: A Qualitative Study

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2018 Apr 8
PMID 29626746
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To understand how people who inject drugs (PWID) experience skin and soft tissue infections (SSTI) and make decisions to seek or delay medical treatment.

Methods: We conducted semi-structured, in-depth interviews in 2015 with 19 PWID at a syringe exchange program in Philadelphia. We analyzed the data using standard qualitative techniques.

Results: PWID described adequate knowledge about SSTI, although they could not always implement knowledge about SSTI prevention due to environmental constraints. Participants reported different experiences with incident SSTI. Some sought immediate medical care at initial presentation. Most, however, waited to seek care. Previous positive and negative healthcare experiences, both in general -including stigma and withdrawal- and specific to SSTI, influenced this decision. Among those who delayed medical care, some reported self-treatment, including increased drug use for pain control, and lancing and draining their own wounds.

Conclusion: Reducing the incidence of SSTI and promoting earlier treatment are important public health priorities. Both require ongoing attention and improvements to the environments in which PWID inject and receive care.

Citing Articles

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients', community organization and healthcare workers' perspectives.

Bedard K, Boisvert I, Rochette M, Racine E, Martel-Laferriere V BMC Infect Dis. 2025; 25(1):221.

PMID: 39953410 PMC: 11829365. DOI: 10.1186/s12879-025-10617-y.


"It always needs a higher level of care than what I can provide": Practical, ethical, and administrative tensions arising from the integration of wound care services into syringe service programs in Maryland.

Sisson L, Block S, Triece T, Martin E, Owczarzak J, Sherman S Int J Drug Policy. 2024; 135():104685.

PMID: 39674056 PMC: 11737354. DOI: 10.1016/j.drugpo.2024.104685.


Social determinants of injection drug use-associated bacterial infections and treatment outcomes: systematic review and meta-analysis.

Brothers T, Lewer D, Bonn M, Kim I, Comeau E, Figgatt M medRxiv. 2024; .

PMID: 39398993 PMC: 11469356. DOI: 10.1101/2024.09.20.24313898.


The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.

Morgan B, Lancaster R, Boyagoda B, Ananda R, Attwood L, Jacka D BMC Infect Dis. 2024; 24(1):299.

PMID: 38454356 PMC: 10918955. DOI: 10.1186/s12879-024-09143-0.


Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.

Brothers T, Lewer D, Jones N, Colledge-Frisby S, Farrell M, Hickman M PLoS Med. 2022; 19(7):e1004049.

PMID: 35853024 PMC: 9295981. DOI: 10.1371/journal.pmed.1004049.